Please login to the form below

Not currently logged in
Email:
Password:

GlycoVaxyn

This page shows the latest GlycoVaxyn news and features for those working in and with pharma, biotech and healthcare.

GSK buys vaccine specialist GlycoVaxyn for $190m

GSK buys vaccine specialist GlycoVaxyn for $190m

Acquisition will expand GSK’s early vaccines pipeline.  . GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline. ... GSK already owned a stake in GlycoVaxyn and had been working

Latest news

  • Janssen boosts vaccines pipeline with GlycoVaxyn deal

    He said: “This collaboration is a further confirmation of the position GlycoVaxyn is about to occupy in the vaccine development space. ... The whole team is dedicated to establish GlycoVaxyn's technology as a powerful platform able to generate

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics